Dr. Sulochana Manandhar is a postdoctoral molecular microbiologist with a research focus on bacterial infections in neonatal populations, antimicrobial resistance mechanisms, and antimicrobial stewardship. She brings extensive laboratory research experience and a passion for locally-driven, evidence-based innovation that addresses public health priorities in Nepal while contributing to global scientific advancement.
At OUCRU Nepal, Dr. Manandhar has led and contributed to several key research projects, including studies on neonatal sepsis, antimicrobial stewardship, hospital infection outbreaks, AMR surveillance (ACORN), and adaptive clinical trials for influenza (AD-ASTRA) and SARS-CoV-2 (PLATCOV). She is currently leading her first clinical study under the MODRA seed award, investigating the prevalence and risk factors of vertically transmitted infections caused by Group B Streptococci (GBS) among pregnant women and newborns in Nepal.
